76,400 Shares in Encompass Health Corporation $EHC Purchased by Canada Pension Plan Investment Board

Key Points

• Canada Pension Plan Investment Board acquired 76,400 Encompass Health shares worth approximately $7.7 million, while institutional investors collectively own 97.25% of the company.
• Analysts remain positive, with a consensus “Buy” rating and an average price target of $148.71; the stock recently traded at $120.98.
• Encompass Health exceeded quarterly earnings and revenue expectations, reporting $1.55 in EPS and $1.60 billion in revenue, while raising its quarterly dividend from $0.19 to $0.21 per share.

Canada Pension Plan Investment Board acquired a new position in Encompass Health Corporation (NYSE:EHC - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 76,400 shares of the company's stock, valued at approximately $7,723,000. Canada Pension Plan Investment Board owned approximately 0.08% of Encompass Health as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of EHC. Legal & General Group Plc acquired a new position in shares of Encompass Health during the 2nd quarter worth approximately $14,405,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Encompass Health in the second quarter valued at approximately $13,532,000. L2 Asset Management LLC acquired a new stake in shares of Encompass Health in the second quarter valued at approximately $492,000. Meiji Yasuda Asset Management Co Ltd. bought a new stake in shares of Encompass Health in the second quarter valued at approximately $235,000. Finally, Globeflex Capital L P bought a new stake in shares of Encompass Health in the second quarter valued at approximately $1,118,000. Institutional investors own 97.25% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on EHC shares. Wall Street Zen upgraded Encompass Health from a "hold" rating to a "buy" rating in a research note on Sunday, August 16th. Leerink Partners set a $152.00 target price on Encompass Health in a research report on Friday, May 22nd. Barclays increased their target price on Encompass Health from $140.00 to $144.00 and gave the stock an "overweight" rating in a report on Thursday, August 6th. TD Cowen boosted their price target on Encompass Health from $125.00 to $140.00 and gave the company a "buy" rating in a research note on Monday, August 10th. Finally, Weiss Ratings raised shares of Encompass Health from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Wednesday, August 12th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $148.71.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, EVP John Patrick Darby sold 8,906 shares of Encompass Health stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.95, for a total value of $1,121,710.70. Following the transaction, the executive vice president owned 75,041 shares in the company, valued at $9,451,413.95. The trade was a 10.61% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Mark J. Tarr sold 173,148 shares of the business's stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.47, for a total value of $21,724,879.56. Following the transaction, the chief executive officer directly owned 267,814 shares of the company's stock, valued at approximately $33,602,622.58. The trade was a 39.27% decrease in their position. The SEC filing for this sale provides additional information. 1.80% of the stock is owned by corporate insiders.

Encompass Health Stock Performance

NYSE EHC opened at $120.98 on Friday. The firm's 50 day simple moving average is $113.20 and its 200 day simple moving average is $107.18. The firm has a market capitalization of $11.93 billion, a price-to-earnings ratio of 19.70, a P/E/G ratio of 2.45 and a beta of 0.72. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 1 year low of $92.77 and a 1 year high of $127.99.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.48 by $0.07. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same period in the previous year, the business earned $1.40 earnings per share. The company's revenue was up 9.6% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. As a group, research analysts expect that Encompass Health Corporation will post 6.08 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be issued a dividend of $0.21 per share. This is an increase from Encompass Health's previous quarterly dividend of $0.19. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health's payout ratio is presently 12.38%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source